Clinical Investigation

Cost-effectiveness of GnRH antagonist implementation on hCG injection day
  • Ayşe Zehra Özdemir
  • Bülent Ayas
  • Davut Güven
  • Aysın Pınar Türkmen
  • Çağrı Gülümser
Turk J Obstet Gynecol 2019; 16: 29-34 DOI: 10.4274/tjod.galenos.2019.56255 PMID:31019837

Clinical Investigation

Comparison of microdose GnRH agonist protocol with GnRH antagonist / letrazole protocol in patients with poor ovarian response
  • Yiğit Çakıroğlu
  • Şule Yıldırım Köpük
  • Orkun Başarır
  • Serdar Filiz
  • Birol Vural
Turk J Obstet Gynecol 2013; 10: 132-137 DOI: 10.5505/tjod.2013.79027
What should be the protocol selection after failure of in-vitro fertilization at normoresponder patients: Agonist or antagonist?
  • Seyit Temel Ceyhan
  • Yeşim Bayoğlu Tekin
  • Mehmet Sakinci
  • Cihangir Mutlu Ercan
  • Uğur Keskin
Turk J Obstet Gynecol 2014; 11: 198-202 DOI: 10.4274/tjod.03789 PMID:28913019
Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
  • Sadık Şahin
  • Selçuk Selçuk
  • Belgin Devranoğlu
  • Tayfun Kutlu
  • Melda Kuyucu
  • Mustafa Eroğlu
Turk J Obstet Gynecol 2014; 11: 203-206 DOI: 10.4274/tjod.80090 PMID:28913020

Review

THE USE OF GnRH ANTAGONISTS IN OVARIAN STIMULATION FOR INTRAUTERINE INSEMINATION
  • Mete Işıkoğlu
Turk J Obstet Gynecol 2013; 10: 250-255 DOI: 10.5505/tjod.2013.82698